1.Senna-containing
laxatives: excretion in the breast milk? Faber P;
Strenge-Hesse A, Geburtshilfe Frauenheilkd 1989
Nov;49(11):958-6
|
|
2.Two-year
carcinogenicity study with sennosides
in the rat: emphasis on gastro-intestinal alterations.
Lyd’en-Sokolowski A; Nilsson A; Sioberrg P, Pharmacology;
VOL 47 Suppl 1, 1993, P209-15
|
|
3.
Acute hemorrhagic colitis following administration
of sennosides A and B (letter), Villand
J, Presse Med, 14(2):104-5 1985 Jan 19
|
|
4.
Influence of a highly purified senna extract on
colonic epithelium. van Gorkom BA; Karrenbeld A;
van Der Sluis T; Koudstaal J; de Vries EG; Kleibeuker
JH, Digestion, 61(2):113-20 2000
|
|
5.
Analytics of senna drugs with regard to the toxicological
discussion of anthranoids., Grimminger W; Witthohn
K, Pharmacology, 47 Suppl 1(-HD-):98-109 1993 Oct
|
|
6.
Genotoxicity of sennosides on the
bone marrow cells of mice. Mukhopadhyay MJ; Saha
A; Dutta A; De B;Mukherjee A, Food Chem Toxicol
36(11):937-40 1998 Nov
|
|
7.
Sennosides
and human colonic motility. Staumont G; Frexinos
J; Fioramonti J; Bu’eno L Pharmacology, 36 Suppl
1 (-HD-):49-56 1988
|
|
8.
Long-term mucosal alterations by sennosides
and related compounds. Dufour P; Gendre P Pharmacology
36 Suppl 1(-HD-):194-202 1988
|
|
9.
Laxative potency and acute toxicity of some anthraquinone
derivatives, senna extracts and fractions of senna
extracts. Hietala P; Marvola M; Parviainen T; Laininen
H, Pharmacol Toxicol,
61(2):153-6 1987 Aug
|
|
10.
Toxic effects of sennosides in laboratory
animals and in vitro. Mengs U, Pharmacology, 36
Suppl 1(-HD-):180-7 1988
|
|
11.
Review article: anthranoid laxatives and their potential
carcinogenic effects. van Gorkom BA ; de Vries EG
; Karrenbeld A ; Kleibeuker JH, Aliment Pharmacol
Ther, 13(4):443-52 1999 Apr
|
12.
Measurement of the intestinal clearance of alpha
1-antitrypsin and the exchangeable potassium pool
in elderly patients treated with anthraquinone glycosides.
Emeriau JP ; Manciet G ; Borde C ; Raynal F ; Galley
P, Gastroenterol Clin
Biol; VOL 7, ISS 10, 1983, P799-801
|
|
13.
Two-year carcinogenicity study with sennosides
in the rat: emphasis on gastro-intestinal alterations.
Lyd´en-Sokolowski A ; Nilsson A ; Sj¨oberg P, Pharmacology,
47 Suppl 1(-HD-) :209-15 1993 Oct
|
|
14.
Ultrastructure of mouse intestinal mucosa and changes
observed after long term anthraquinone administration.
Dufour P ; Gendre P, Gut; VOL 25, ISS 12, 1984,
P1358-63
|
|
15.
The genotoxicity status of senna. Heidemann A ;
Miltenburger HG ; Mengs U, Pharmacology, 47 Suppl
1(-HD-)
:178-86 1993 Oct
|
|
16.
Effects of ‘contact laxatives’ on intestinal and
colonic epithelial cell proliferation. Geboes K
; Nijs G ; Mengs U ; Geboes KP ; Van Damme A ; de
Witte P, Pharmacology, 47 Suppl 1(-HD-):187-95 1993
Oct
|
|
17.
Effect of sennosides and related compounds
on intestinal transit in the rat. Leng-Peschlow
E, Pharmacology, 36 Suppl 1(-HD-):40-8 1988
|
|
|
18.
Reproductive toxicological investigations with sennosides.
Mengs U, Arzneimittelforschung, 36(9):1355-8 1986
Sep
|
|
19.
Effect of sennosides on colon motility
in dogs. Fioramonti J ; Staumont G ; Garcia-Villar
R ; Bu´eno L, Pharmacology, 36 Suppl 1(-HD-):23-30
1988
|
|
20.
Effects of sennosides on colonic myoelectrical
activity in man. Frexinos J ; Staumont G ; Fioramonti
J ; Bueno L, Dig Dis Sci, 34(2):214-9 1989 Feb
|
|
21.
Effects of long-term sennoside treatment
on in vitro motility of rat colon. Odenthal KP ;
Leng-Peschlow E ; Voderholzer W ; M¨uller-Lissner
S, Pharmacology, 47 Suppl 1(-HD-):146-54 1993 Oct
|
22.
Chronic sennoside treatment does not
cause habituation and secondary hyperaldosteronism
in rats. Leng-Peschlow E ; Odenthal KP ; Voderholzer
W ; M¨uller-Lissner S, Pharmacology, 47 Suppl 1(-HD-):162-71
1993 Oct
|
|
23.
Evaluation of the potential carcinogenic activity
of Senna and Cascara glycosides for the rat colon.
Mereto E ; Ghia M ; Brambilla G, Cancer Lett, 101(1):79-83
1996 Mar 19
|